Results 21 to 30 of about 84,543 (289)

Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents [PDF]

, 2016
Association between HCV infection and diabetes has been widely postulated. Little is known about the impact of direct acting antiviral agents (DAAs) on glycemic control. Aim of our study was to evaluate the glycemic control modifications in a case series
D'Ettorre, G., LICHTNER, Miriam, MAROCCO, RAFFAELLA, MASTROIANNI, Claudio Maria, MEZZAROMA, Ivano, Passavanti, G., pavone, paolo, TIEGHI, TIZIANA, VITTOZZI, PIETRO, VULLO, Vincenzo   +9 more
core   +1 more source

Second-line Medication Preference in Patients with Type 2 Diabetes: a Study Based on a Discrete Choice Experiment [PDF]

Zhongguo quanke yixue
Background With the continuous improvement of diabetes prevention and treatment strategies, clinical guidelines recommend first-line hypoglycemic agents while emphasizing a "patient-centered", and the selection of appropriate second-line ...
LIU Zhigang, LIU Shimeng, ZHENG Lyuyun, XUE Wenjing, CAO Chenchen, LIU Jing, CHEN Yingyao
doaj   +1 more source

Glycated albumin and hemoglobin A1c levels and cause-specific mortality by patients’ conditions among hemodialysis patients with diabetes: a 3-year nationwide cohort study

BMJ Open Diabetes Research & Care, 2020
Introduction Differences in mortality and cause-specific mortality rates according to glycated albumin (GA) and hemoglobin A1c (HbA1c) levels among dialysis patients with diabetes based on hypoglycemic agent use and malnutrition status remain unclear ...
Takayuki Hamano, Masanori Abe, Atsushi Wada, Kenmei Takaichi, Shigeru Nakai, Ikuto Masakane, Kosaku Nitta   +6 more
doaj   +1 more source

Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus

Cardiovascular Diabetology, 2023
Background Although sodium-glucose cotransporter 2 inhibitors (SGLT2i) have demonstrated cardiovascular benefits in patients with type 2 diabetes mellitus, real-world evidence regarding their benefits to diabetic patients with acute myocardial infarction
Young Sang Lyu, Seok Oh, Jin Hwa Kim, Sang Yong Kim, Myung Ho Jeong   +4 more
doaj   +1 more source

Post-Transplant Diabetes: Prevalence, Risk, and Management Challenges

Dubai Diabetes and Endocrinology Journal, 2022
The prevalence of diabetes and diabetic nephropathy is increasing, especially in middle eastern countries. Many patients reach end-stage renal disease and either start dialysis or consider preemptive transplantation.
Alaaeldin M.K. Bashier, Dileep Kumar, Fakhriya J. Alalawi, Hind Al Nour, Amna Khalifa Al Hadari, Azza Abdulaziz Bin Hussain   +5 more
doaj   +1 more source

Successful Management of a Patient with Florid Diabetic Retinopathy [PDF]

, 2016
Florid diabetic retinopathy is an unusual, aggressive type of diabetic retinopathy. It is seen in young patients with poor metabolic control. Despite advances in treatment the overall prognosis of this condition remains poor. A 21-year old female patient
Ahmad SS, Ghani SA, Alexander SM
core   +1 more source

The Study of Hypoglycemic Activity of 7-Terpenylcoumarins

Molecules, 2022
Natural and synthetic coumarins are often considered privileged scaffolds for obtaining pharmacological agents with hypoglycemic activity. Chemical modification of coumarins often leads to antidiabetic agents with greater efficacy.
Sergey Kuranov, Mariya Marenina, Dmitriy Ivankin, Mikhail Blokhin, Sergey Borisov, Tatyana Khomenko, Olga Luzina, Mikhail Khvostov, Konstantin Volcho, Tatyana Tolstikova, Nariman Salakhutdinov   +10 more
doaj   +1 more source

Current status of diabetes treatment in Miyazaki Prefecture, Japan: Results of a questionnaire survey conducted in 2016 and 2020

Journal of Diabetes Investigation, 2022
Aims/Introduction The Japanese diabetes treatment guidelines do not specify the first choice of hypoglycemic agents, unlike those of Western countries. Furthermore, the current situation in diabetes treatment is that the choice of hypoglycemic agents is ...
Yudai Uehira, Hiroaki Ueno, Emi Ebihara, Taisuke Uchida, Hiroki Nabekura, Hideyuki Sakoda, Tadato Yonekawa, Hideki Yamaguchi, Masamitsu Nakazato   +8 more
doaj   +1 more source

When intensive insulin therapy (MDi) fails in patients with type 2 diabetes: Switching to GLP-1 receptor agonist versus insulin pump [PDF]

, 2016
Treatment with insulin, alone or with oral or injectable hypoglycemic agents, is becoming increasingly common in patients with type 2 diabetes. However, approximately 40% of patients fail to reach their glycemic targets with the initially prescribed ...
Castaneda, Javier, Cohen, Ohad, FILETTI, SEBASTIANO, Glandt, Mariela, MARANGHI, MARIANNA   +4 more
core   +2 more sources

Case Report: Recurrent Autoimmune Hypoglycemia Induced by Non-Hypoglycemic Medications

Frontiers in Immunology, 2022
We present a case of recurrent autoimmune hypoglycemia induced by non-hypoglycemic agents. We review reported cases of autoimmune hypoglycemia related to non-hypoglycemic agents, and discuss the effects of different detection methods for insulin ...
Qiuping Zhu, Qiuping Zhu, Hanxin Zhao, Wei Qiu, Fang Wu, Chungen Qian, Chungen Qian, Yonghong Yang, Ye Kang, Fenping Zheng, Jiaqiang Zhou   +10 more
doaj   +1 more source